Penumbra, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$28Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
17,789clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $3.3M
2020 $1.7M
2021 $2.2M
2022 $3.7M
2023 $4.8M
2024 $5.6M
2025 $6.6M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Vascular & Interventional Radiology $6.4M
Vascular Surgery $5.3M
Interventional Cardiology $4.4M
Diagnostic Radiology $4.0M
Neurological Surgery $2.0M
Cardiovascular Disease $1.7M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Donald Frei Englewood, CO Diagnostic Radiology $969,516.71
Santhosh Mathews Bradenton, FL Interventional Cardiology $878,558.72
Frank Arko Charlotte, NC Vascular Surgery $682,069.32
Patrick Muck Cincinnati, OH Vascular Surgery $371,382.45
Suhail Dohad Beverly Hills, CA Interventional Cardiology $367,445.14
Constantino Pena Miami, FL Diagnostic Radiology $264,658.51
Blaise Baxter San Francisco, CA Vascular & Interventional Radiology $250,871.19
Parag Patel Milwaukee, WI Vascular & Interventional Radiology $224,898.70
Mazin Foteh Austin, TX Vascular Surgery $224,498.37
Martyn Knowles Raleigh, NC Surgery $220,205.13

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.